|
Market Closed -
Nasdaq
00:00:00 03/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 139.37 USD | -3.78% |
|
+0.68% | +59.57% |
| 10-23 | UK approves J&J's oral psoriasis pill | RE |
| 10-12 | UBS Initiates Coverage on Protagonist Therapeutics With Buy Rating, $184 Price Target | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -3.78% | +0.68% | +0.13% | +2.00% | +59.57% | +77.27% | +822.37% | +322.85% | +679.91% | 9.37B | |
| -2.37% | -4.19% | -17.14% | +7.96% | +52.97% | +39.49% | +63.21% | +6.51% | - | 63.77B | |
| -2.87% | +0.23% | -6.84% | +5.23% | +9.38% | +11.11% | +68.89% | +196.41% | +5,618.45% | 56.37B | |
| +0.62% | +2.60% | +15.63% | +15.30% | +20.53% | +16.96% | +103.45% | -15.07% | +251.90% | 54.62B | |
| -3.33% | -7.49% | -0.87% | +9.97% | +14.65% | +19.39% | +43.57% | -0.17% | +260.65% | 44.06B | |
| -2.45% | -4.33% | +0.70% | +14.32% | +18.91% | +16.36% | +99.27% | +1.07% | +980.68% | 42.11B | |
| -1.64% | +0.63% | -8.61% | +0.34% | +136.25% | +219.80% | +824.67% | +504.66% | - | 41B | |
| -5.47% | +39.86% | +59.88% | +98.98% | +82.44% | +101.20% | +80.57% | +28.90% | +247.56% | 34.92B | |
| +0.21% | -1.23% | +4.58% | +2.84% | +11.38% | +14.81% | +47.35% | +13.64% | +157.52% | 32.82B | |
| -2.90% | +17.05% | +0.66% | +10.86% | -37.19% | -42.35% | +337.41% | +252.05% | +747.36% | 24.7B | |
| +0.27% | -2.62% | -20.43% | +15.13% | +41.86% | +23.20% | -6.89% | -60.00% | - | 23.27B | |
| -0.73% | -0.66% | -9.62% | -3.37% | -8.06% | -15.76% | -6.33% | -68.09% | - | 22.15B | |
| -0.59% | -3.15% | +8.37% | +12.31% | +15.40% | +10.81% | +157.60% | +186.27% | +2,128.05% | 18.24B | |
| -5.81% | -1.98% | +18.03% | +45.60% | +69.71% | +88.00% | +102.09% | -23.11% | +356.99% | 17.16B | |
| +0.34% | +3.92% | +18.08% | +29.14% | +41.06% | +43.96% | +81.86% | -15.04% | +118.52% | 17B | |
| +1.07% | +8.68% | +21.04% | +32.25% | +60.00% | +81.36% | +233.63% | +223.18% | +538.71% | 16.93B | |
| -0.91% | +2.31% | +9.53% | +2.08% | - | - | - | - | - | 16.5B | |
| -2.94% | +10.72% | +26.75% | +25.42% | +12.58% | +19.39% | -17.94% | -29.00% | +165.04% | 15.83B | |
| 0.00% | +2.59% | +1.71% | +12.26% | +180.86% | +165.07% | +345.26% | +1,394.79% | +769.37% | 15.11B | |
| +8.67% | +16.07% | +2.59% | +78.89% | +32.90% | -12.65% | - | - | - | 13.03B | |
| Average | -1.75% | +5.40% | +6.21% | +20.88% | +42.91% | +46.18% | +187.78% | +162.21% | +930.05% | 28.95B | |
| Weighted average by Cap. | -1.84% | +4.80% | +4.06% | +18.15% | +39.64% | +44.42% | +161.07% | +120.75% | +1,232.83% |
- Stock Market
- Stocks
- PTGX Stock
- Sector Protagonist Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
